Methods for removing triazine from N-methylimidazole for synthesis of oligonucleotide

US9556124B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9556124-B2
Application numberUS-201414471635-A
CountryUS
Kind codeB2
Filing dateAug 28, 2014
Priority dateOct 31, 2013
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for removing 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from a N-methylimidazole and methods for making oligonucleotides using N-methylimidazole are provided. In one embodiment, a method for removing 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from a feedstock containing N-methylimidazole includes contacting the feedstock with small or medium pore molecular sieves. The small or medium pore molecular sieves adsorb 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from the feedstock. The method further includes separating the small or medium pore molecular sieves from the feedstock.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for removing 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from a feedstock containing N-methylimidazole, the method comprising: contacting the feedstock with small or medium pore molecular sieves, wherein the small or medium pore molecular sieves adsorb 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from the feedstock; and separating the small or medium pore molecular sieves from the feedstock. 2. The method of claim 1 wherein contacting the feedstock with small or medium pore molecular sieves comprises contacting the feedstock with synthetic molecular sieves having a pore aperture size of no more than about 0.6 nm. 3. The method of claim 2 wherein contacting the feedstock with small or medium pore molecular sieves comprises contacting the feedstock with silicoaluminophosphate (SAPO) molecular sieves. 4. The method of claim 3 wherein contacting the feedstock with small or medium pore molecular sieves comprises contacting the feedstock with SAPO-34 molecular sieves. 5. The method of claim 1 wherein contacting the feedstock with small or medium pore molecular sieves comprises: mixing the feedstock with the small or medium pore molecular sieves in a chamber, heating the chamber to form a reflux of condensed vapor, and returning the reflux to the chamber. 6. The method of claim 1 further comprising the step of heating the small or medium pore molecular sieves and the feedstock to the boiling point of the feedstock for at least about 3 minutes. 7. The method of claim 1 wherein separating the small or medium pore molecular sieves from the feedstock forms a supernatant containing the N-methylimidazole, and wherein the method further comprises fractionating the supernatant to obtain an N-methylimidazole product. 8. The method of claim 1 wherein the feedstock has a 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine concentration of about 200 parts per million (ppm) to about 1100 ppm, and wherein separating the small or medium pore molecular sieves from the feedstock comprises isolating a supernatant with a 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine concentration of about 0 ppm to about 20 ppm. 9. The method of claim 1 wherein contacting the feedstock with small or medium pore molecular sieves comprises contacting the small or medium pore molecular sieves with the feedstock in a ratio between about 0.5 grams (g) of the small or medium pore molecular sieves per 100 milliliters (ml) of feedstock to about 8 g of the small or medium pore molecular sieves per 100 ml of feedstock. 10. The method of claim 1 wherein contacting the feedstock with small or medium pore molecular sieves comprises contacting the small or medium pore molecular sieves with the feedstock in a ratio of about 2.5 grams (g) of the small or medium pore molecular sieves per 100 milliliters (ml) of feedstock.

Assignees

Inventors

Classifications

  • C07D233/58Primary

    with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms · CPC title

  • with deoxyribosyl as saccharide radical · CPC title

  • Processes for the preparation of sugar derivatives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9556124B2 cover?
Methods for removing 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from a N-methylimidazole and methods for making oligonucleotides using N-methylimidazole are provided. In one embodiment, a method for removing 1,3,5-trimethylhexahydro-1,3,5-triazine and N-methylenemethanamine from a feedstock containing N-methylimidazole includes contacting the feedstock with small or medi…
Who is the assignee on this patent?
Honeywell Int Inc
What technology area does this patent fall under?
Primary CPC classification C07D233/58. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).